Publications by authors named "Ts-Ting Lin"

Claim this Profile
C
Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Yun-Chieh Sung, Ya-Chi Liu, Po-Han Chao, Chih-Chun Chang, Pei-Ru Jin, Ts-Ting Lin, Ja-An Lin, Ling-Hsuan Chen

Theranostics· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.
Yunching Chen, Ya-Chi Liu, Yun-Chieh Sung, Rakesh R Ramjiawan, Ts-Ting Lin

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Ts-Ting Lin, Dong-Yu Gao, Ya-Chi Liu, Yun-Chieh Sung, Dehui Wan

J Control Release· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Jia-Yu Liu, Tsaiyu Chiang, Chun-Hung Liu, Guann-Gen Chern, Ts-Ting Lin

Mol Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
Dong-Yu Gao, Ts-Ting Lin, Yun-Chieh Sung, Ya Chi Liu, Wen-Hsuan Chiang

Biomaterials· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis